Literature DB >> 24807918

Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer.

Shipra Das1, Adrian R Krainer2.   

Abstract

Serine/Arginine Splicing Factor 1 (SRSF1) is the archetype member of the SR protein family of splicing regulators. Since its discovery over two decades ago, SRSF1 has been repeatedly surprising and intriguing investigators by the plethora of complex biologic pathways it regulates. These include several key aspects of mRNA metabolism, such as mRNA splicing, stability, and translation, as well as other mRNA-independent processes, such as miRNA processing, protein sumoylation, and the nucleolar stress response. In this review, the structural features of SRSF1 are discussed as they relate to the intricate mechanism of splicing and the multiplicity of functions it performs. Similarly, a list of relevant alternatively spliced transcripts and SRSF1 interacting proteins is provided. Finally, emphasis is given to the deleterious consequences of overexpression of the SRSF1 proto-oncogene in human cancers, and the complex mechanisms and pathways underlying SRSF1-mediated transformation. The accumulated knowledge about SRSF1 provides critical insight into the integral role it plays in maintaining cellular homeostasis and suggests new targets for anticancer therapy. Mol Cancer Res; 12(9); 1195-204. ©2014 AACR. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24807918      PMCID: PMC4163531          DOI: 10.1158/1541-7786.MCR-14-0131

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  97 in total

1.  Involvement of SR proteins in mRNA surveillance.

Authors:  Zuo Zhang; Adrian R Krainer
Journal:  Mol Cell       Date:  2004-11-19       Impact factor: 17.970

2.  The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression.

Authors:  Teresa Ezponda; María J Pajares; Jackeline Agorreta; José I Echeveste; José M López-Picazo; Wenceslao Torre; Ruben Pio; Luis M Montuenga
Journal:  Clin Cancer Res       Date:  2010-08-03       Impact factor: 12.531

3.  Interaction between the RNA binding domains of Ser-Arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome assembly.

Authors:  Suhyung Cho; Amy Hoang; Rahul Sinha; Xiang-Yang Zhong; Xiang-Dong Fu; Adrian R Krainer; Gourisankar Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

4.  A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm.

Authors:  J F Cáceres; G R Screaton; A R Krainer
Journal:  Genes Dev       Date:  1998-01-01       Impact factor: 11.361

5.  Processive phosphorylation of alternative splicing factor/splicing factor 2.

Authors:  Brandon E Aubol; Sutapa Chakrabarti; Jacky Ngo; Jennifer Shaffer; Brad Nolen; Xiang-Dong Fu; Gourisankar Ghosh; Joseph A Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

6.  Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing.

Authors:  Tatyana Novoyatleva; Bettina Heinrich; Yesheng Tang; Natalya Benderska; Matthew E R Butchbach; Christian L Lorson; Monique A Lorson; Claudia Ben-Dov; Pascale Fehlbaum; Laurent Bracco; Arthur H M Burghes; Mathieu Bollen; Stefan Stamm
Journal:  Hum Mol Genet       Date:  2007-10-02       Impact factor: 6.150

7.  Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.

Authors:  F Rossi; E Labourier; T Forné; G Divita; J Derancourt; J F Riou; E Antoine; G Cathala; C Brunel; J Tazi
Journal:  Nature       Date:  1996-05-02       Impact factor: 49.962

8.  Efficiency of the pioneer round of translation affects the cellular site of nonsense-mediated mRNA decay.

Authors:  Hanae Sato; Nao Hosoda; Lynne E Maquat
Journal:  Mol Cell       Date:  2008-02-01       Impact factor: 17.970

9.  The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.

Authors:  R Tacke; J L Manley
Journal:  EMBO J       Date:  1995-07-17       Impact factor: 11.598

10.  Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing.

Authors:  Madapura M Pradeepa; Heidi G Sutherland; Jernej Ule; Graeme R Grimes; Wendy A Bickmore
Journal:  PLoS Genet       Date:  2012-05-17       Impact factor: 5.917

View more
  116 in total

1.  Proteomic Maps of Human Gastrointestinal Stromal Tumor Subgroups.

Authors:  Yu Liu; Zhigui Li; Zhiqiang Xu; Xiuxiu Jin; Yanqiu Gong; Xuyang Xia; Yuqin Yao; Zhaofen Xu; Yong Zhou; Heng Xu; Shuangqing Li; Yong Peng; Xiaoting Wu; Lunzhi Dai
Journal:  Mol Cell Proteomics       Date:  2019-02-25       Impact factor: 5.911

Review 2.  Alternative splicing and cancer metastasis: prognostic and therapeutic applications.

Authors:  Diego M Marzese; Ayla O Manughian-Peter; Javier I J Orozco; Dave S B Hoon
Journal:  Clin Exp Metastasis       Date:  2018-05-29       Impact factor: 5.150

Review 3.  Human Papillomavirus E2 Protein: Linking Replication, Transcription, and RNA Processing.

Authors:  Sheila V Graham
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

4.  Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia.

Authors:  Jianbiao Zhou; Wee-Joo Chng
Journal:  Stem Cell Investig       Date:  2017-02-09

5.  SRSF1-Regulated Alternative Splicing in Breast Cancer.

Authors:  Olga Anczuków; Martin Akerman; Antoine Cléry; Jie Wu; Chen Shen; Nitin H Shirole; Amanda Raimer; Shuying Sun; Mads A Jensen; Yimin Hua; Frédéric H-T Allain; Adrian R Krainer
Journal:  Mol Cell       Date:  2015-10-01       Impact factor: 17.970

6.  Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.

Authors:  Meiling Zhang; Bo Zhu; Judith Davie
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

Review 7.  Quick or quality? How mRNA escapes nuclear quality control during stress.

Authors:  Gesa Zander; Heike Krebber
Journal:  RNA Biol       Date:  2017-07-31       Impact factor: 4.652

Review 8.  The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression.

Authors:  Asaf Shilo; Zahava Siegfried; Rotem Karni
Journal:  Mol Cell Oncol       Date:  2014-12-01

9.  Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma.

Authors:  Yuan Zhao; Bo Zhang; Yu Lei; Jingying Sun; Yaohua Zhang; Sen Yang; Xuejun Zhang
Journal:  Tumour Biol       Date:  2016-07-25

Review 10.  The neurogenetics of alternative splicing.

Authors:  Celine K Vuong; Douglas L Black; Sika Zheng
Journal:  Nat Rev Neurosci       Date:  2016-05       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.